{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T19:43:46Z","timestamp":1781120626021,"version":"3.54.1"},"reference-count":287,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.phrs.2018.01.013","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T11:39:15Z","timestamp":1517398755000},"page":"390-408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"special_numbering":"C","title":["Gut microbiota, hypertension and chronic kidney disease: Recent advances"],"prefix":"10.1016","volume":"144","author":[{"given":"Antonio","family":"Sircana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"De Michieli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Parente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Framarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Berrutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Paschetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Bongiovanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Musso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2018.01.013_bib0005","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1152\/physrev.00045.2009","article-title":"Gut microbiota in health and disease","volume":"90","author":"Sekirov","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2018.01.013_bib0010","first-page":"26191","article-title":"Dysbiosis of the gut microbiota in disease","volume":"26","author":"Carding","year":"2015","journal-title":"Microb. Ecol. Health Dis."},{"key":"10.1016\/j.phrs.2018.01.013_bib0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2018.01.013_bib0020","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.2337\/dc15-1182","article-title":"Fatty liver and chronic kidney disease: novel mechanistic insights and therapeutic opportunities","volume":"39","author":"Musso","year":"2016","journal-title":"Diabetes Care"},{"issue":"February (1)","key":"10.1016\/j.phrs.2018.01.013_bib0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/MOL.0b013e3283347ebb","article-title":"Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders","volume":"21","author":"Musso","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev-med-012510-175505","article-title":"Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes","volume":"62","author":"Musso","year":"2011","journal-title":"Annu. Rev. Med."},{"issue":"January","key":"10.1016\/j.phrs.2018.01.013_bib0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.trsl.2016.04.007","article-title":"Gut microbiome in chronic kidney disease: challenges and opportunities","volume":"179","author":"Nallu","year":"2017","journal-title":"Transl. Res."},{"key":"10.1016\/j.phrs.2018.01.013_bib0040","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","article-title":"A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2018.01.013_bib0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/ajh\/hpu083","article-title":"Essential hypertension vs. secondary hypertension among children","volume":"28","author":"Guptamalhotra","year":"2015","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.phrs.2018.01.013_bib0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrneph.2015.191","article-title":"The gut microbiome, diet, and links to cardiometabolic and chronic disorders","volume":"12","author":"Aron-Wisnewsky","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"September","key":"10.1016\/j.phrs.2018.01.013_bib0055","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.biopha.2017.06.066","article-title":"The impact of gutmicrobiota on kidneyfunction and pathogenesis","volume":"93","author":"Mahmoodpoor","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"October (10)","key":"10.1016\/j.phrs.2018.01.013_bib0060","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2337\/dc10-0556","article-title":"Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?","volume":"33","author":"Musso","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2018.01.013_bib0065","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the human intestinal microbial flora","volume":"308","author":"Eckburg","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.phrs.2018.01.013_bib0070","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nature09199","article-title":"Viruses in the faecal microbiota of monozygotic twins and their mothers","volume":"466","author":"Reyes","year":"2010","journal-title":"Nature"},{"issue":"December (24)","key":"10.1016\/j.phrs.2018.01.013_bib0075","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2018.01.013_bib0080","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1126\/science.aad3369","article-title":"Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity","volume":"352","author":"Zhernakova","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.phrs.2018.01.013_bib0085","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1126\/science.aad3503","article-title":"Population-level analysis of gut microbiome variation","volume":"352","author":"Falony","year":"2016","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.phrs.2018.01.013_bib0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4161\/gmic.19897","article-title":"Microbial degradation of complex carbohydrates in the gut","volume":"3","author":"Flint","year":"2012","journal-title":"Gut Microbes"},{"issue":"2","key":"10.1016\/j.phrs.2018.01.013_bib0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1753-4887.2010.00365.x","article-title":"Fermentation potential of the gut microbiome: implications for energy homeostasis and weight management","volume":"69","author":"Arora","year":"2011","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.phrs.2018.01.013_bib0100","series-title":"Prevention of Cardiovascular Diseases","author":"WHO","year":"2007"},{"issue":"June (6)","key":"10.1016\/j.phrs.2018.01.013_bib0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1152\/physiolgenomics.00136.2014","article-title":"Evidence for a link between gut microbiota and hypertension in the Dahl rat","volume":"4","author":"Mell","year":"2015","journal-title":"Physiol. Genomics"},{"issue":"June (6)","key":"10.1016\/j.phrs.2018.01.013_bib0110","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1161\/HYPERTENSIONAHA.115.05315","article-title":"Gut dysbiosis is linked to hypertension","volume":"65","author":"Yang","year":"2015","journal-title":"Hypertension"},{"issue":"October (5)","key":"10.1016\/j.phrs.2018.01.013_bib0115","first-page":"475","article-title":"Influence of short-chain fatty acids on vascular tone","volume":"72","author":"Kristev","year":"1991","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0120","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1152\/physiolgenomics.00081.2016","article-title":"Alterations in the gut microbiota can elicit hypertension in rats","volume":"49","author":"Adnan","year":"2017","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.phrs.2018.01.013_bib0125","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/CIRCULATIONAHA.116.024545","article-title":"High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice","volume":"135","author":"Marques","year":"2017","journal-title":"Circulation"},{"issue":"February (2)","key":"10.1016\/j.phrs.2018.01.013_bib0130","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/HYPERTENSIONAHA.115.06672","article-title":"Role of the gut microbiome in obstructive sleep apnea-induced hypertension","volume":"67","author":"Durgan","year":"2016","journal-title":"Hypertension"},{"issue":"February (1)","key":"10.1016\/j.phrs.2018.01.013_bib0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40168-016-0222-x","article-title":"Gut microbiotadysbiosiscontributes to the development of hypertension","volume":"5","author":"Li","year":"2017","journal-title":"Microbiome"},{"issue":"August (24)","key":"10.1016\/j.phrs.2018.01.013_bib0140","article-title":"Beyond gut feelings: how the gut microbiota regulates blood pressure","author":"Marques","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0145","doi-asserted-by":"crossref","first-page":"7646979","DOI":"10.1155\/2016\/7646979","article-title":"A nested case-control study of association between metabolome and hypertension risk","volume":"2016","author":"Hao","year":"2016","journal-title":"BioMed Res. Int."},{"issue":"August (24)","key":"10.1016\/j.phrs.2018.01.013_bib0150","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fcimb.2017.00381","article-title":"Alterations of the gut microbiome in hypertension","volume":"7","author":"Yan","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0155","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1097\/HJH.0b013e328338cd36","article-title":"Periodontal bacteria and hypertension: the oral infections and vascular disease epidemiology study (INVEST)","volume":"28","author":"Desvarieux","year":"2010","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2018.01.013_bib0160","doi-asserted-by":"crossref","first-page":"349e355","DOI":"10.1159\/000189334","article-title":"Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis","volume":"74","author":"Hida","year":"1996","journal-title":"Nephron"},{"key":"10.1016\/j.phrs.2018.01.013_bib0165","doi-asserted-by":"crossref","first-page":"19191930","DOI":"10.1185\/03007990903069249","article-title":"Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada","volume":"25","author":"Ranganathan","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.phrs.2018.01.013_bib0170","doi-asserted-by":"crossref","first-page":"e99006","DOI":"10.1371\/journal.pone.0099006","article-title":"Microbiota and metabolome associated with immunoglobulin A nephropathy (IgAN)","volume":"9","author":"De Angelis","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.01.013_bib0175","doi-asserted-by":"crossref","first-page":"308e315","DOI":"10.1038\/ki.2012.345","article-title":"Chronic kidney disease alters intestinal microbial flora","volume":"83","author":"Vaziri","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2018.01.013_bib0180","doi-asserted-by":"crossref","first-page":"733e738","DOI":"10.1111\/j.1440-1797.2012.01647.x","article-title":"Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients","volume":"17","author":"Wang","year":"2012","journal-title":"Nephrology"},{"key":"10.1016\/j.phrs.2018.01.013_bib0185","doi-asserted-by":"crossref","first-page":"28562862","DOI":"10.1007\/s10620-012-2242-0","article-title":"Gut bacterial translocation contributes to microinflammation in experimental uremia","volume":"57","author":"Wang","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.phrs.2018.01.013_bib0190","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1681\/ASN.2015030279","article-title":"The influence of CKD on colonic microbial metabolism","volume":"27","author":"Poesen","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0195","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/CIRCRESAHA.116.309006","article-title":"Hypertension-linked pathophysiological alterations in the gut","volume":"120","author":"Santisteban","year":"2017","journal-title":"Circ. Res."},{"issue":"July (31)","key":"10.1016\/j.phrs.2018.01.013_bib0200","article-title":"Report of the National Heart, Lung, and Blood Institute working group on the role of microbiota in blood pressure regulation: current status and future directions","author":"Raizada","year":"2017","journal-title":"Hypertension"},{"issue":"September (5)","key":"10.1016\/j.phrs.2018.01.013_bib0205","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/MNH.0000000000000149","article-title":"Gut microbiota in hypertension","volume":"24","author":"Jose","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.phrs.2018.01.013_bib0210","doi-asserted-by":"crossref","first-page":"F1169","DOI":"10.1152\/ajprenal.00630.2012","article-title":"Chronic regulation of the renal Na+\/H+ exchanger NHE3 by dopamine: translational and posttranslational mechanisms","volume":"304","author":"Hu","year":"2013","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"12","key":"10.1016\/j.phrs.2018.01.013_bib0215","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrgastro.2013.180","article-title":"The gut as a sensory organ","volume":"10","author":"Furness","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0220","doi-asserted-by":"crossref","first-page":"227ra36","DOI":"10.1126\/scitranslmed.3007790","article-title":"Intestinal inhibition of the Na+\/H+ exchanger 3 prevents cardiorenal damage in rats and inhibits Na+ uptake in humans","volume":"6","author":"Spencer","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phrs.2018.01.013_bib0225","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1021\/pr2012544","article-title":"Urinary metabolic phenotyping the slc26a6 (chloride-oxalate exchanger) null mouse model","volume":"11","author":"Garcia-Perez","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.phrs.2018.01.013_bib0230","doi-asserted-by":"crossref","DOI":"10.1002\/j.1932-8737.1997.tb00006.x","article-title":"Biology of the endothelium","volume":"20","author":"L\u00fcscher","year":"1997","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0235","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cardiores.2006.11.013","article-title":"Estrogen protection, oxidized LDL, endothelial dysfunction and vasorelaxation in cardiovascular disease: new insights into a complex issue","volume":"73","author":"Subah Packer","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2018.01.013_bib0240","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2174\/187153012803832602","article-title":"Oxidative stress in atherosclerosis development: the central role of LDL and oxidative burst","volume":"12","author":"Peluso","year":"2012","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"issue":"9","key":"10.1016\/j.phrs.2018.01.013_bib0245","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrd4623","article-title":"Strategies to increase nitric oxide signalling in cardiovascular disease","volume":"14","author":"Lundberg","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.phrs.2018.01.013_bib0250","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1194\/jlr.M500507-JLR200","article-title":"Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase","volume":"47","author":"Ma","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2018.01.013_bib0255","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/MNH.0b013e328335f91f","article-title":"Endothelin, hypertension and chronic kidney disease: new insights","volume":"19","author":"Kohan","year":"2010","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"August (8)","key":"10.1016\/j.phrs.2018.01.013_bib0260","article-title":"Bridging the gap between gut microbial dysbiosis and cardiovascular diseases","volume":"9","author":"Lau","year":"2017","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.phrs.2018.01.013_bib0265","doi-asserted-by":"crossref","first-page":"068","DOI":"10.1016\/j.freeradbiomed.2009.01.011","article-title":"Gastroprotective and blood pressure lowering effects of dietary nitrate are abolished by an antiseptic mouthwash","volume":"46","author":"Petersson","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2018.01.013_bib0270","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3945\/jn.112.170233","article-title":"Inorganic nitrate and beetroot juice supplementation reduces blood pressure in adults: a systematic review and meta-analysis","volume":"143","author":"Siervo","year":"2013","journal-title":"J. Nutr."},{"key":"10.1016\/j.phrs.2018.01.013_bib0275","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1079\/PNS2002207","article-title":"Regulation of short-chain fatty acid production","volume":"62","author":"Macfarlane","year":"2003","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.phrs.2018.01.013_bib0280","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/jn\/116.9.1772","article-title":"Short-chain fatty acids in germfree mice and rats","volume":"116","author":"Hoverstad","year":"1986","journal-title":"J. Nutr."},{"issue":"January (1)","key":"10.1016\/j.phrs.2018.01.013_bib0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MNH.0000000000000293","article-title":"The gut microbiome and hypertension","volume":"26","author":"Pevsner-Fischer","year":"2017","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"19","key":"10.1016\/j.phrs.2018.01.013_bib0290","doi-asserted-by":"crossref","first-page":"8030","DOI":"10.1073\/pnas.1016088108","article-title":"Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41)","volume":"108","author":"Kimura","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2018.01.013_bib0295","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1073\/pnas.1215927110","article-title":"Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation","volume":"110","author":"Pluznick","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2018.01.013_bib0300","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1152\/physiolgenomics.00089.2016","article-title":"Microbial short chain fatty acid metabolites lower blood pressure via endothelial G-protein coupled receptor 41","volume":"48","author":"Natarajan","year":"2016","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.phrs.2018.01.013_bib0305","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1073\/pnas.1215927110","article-title":"Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation","volume":"110","author":"Pluznick","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"December (12)","key":"10.1016\/j.phrs.2018.01.013_bib0310","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jash.2016.10.007","article-title":"Gut hormones and gut microbiota: implications for kidney function and hypertension","volume":"10","author":"Afsar","year":"2016","journal-title":"J. Am. Soc. Hypertens."},{"issue":"2","key":"10.1016\/j.phrs.2018.01.013_bib0315","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4161\/gmic.27492","article-title":"Novel SCFA receptor, the microbiota, and blood pressure regulation","volume":"5","author":"Pluznick","year":"2014","journal-title":"Gut Microbes"},{"key":"10.1016\/j.phrs.2018.01.013_bib0320","first-page":"H1378","article-title":"Acetate causes endothelium-independent increases in cyclic AMP in rat caudal artery","volume":"255","author":"Daugirdas","year":"1988","journal-title":"Am. J. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2018.01.013_bib0325","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000356211","article-title":"Short-chainfatty acid receptor and its contribution to glucagon-like peptide-1 release","volume":"89","author":"Kaji","year":"2014","journal-title":"Digestion"},{"key":"10.1016\/j.phrs.2018.01.013_bib0330","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2337\/db11-1019","article-title":"Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2","volume":"61","author":"Tolhurst","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2018.01.013_bib0335","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nrendo.2009.48","article-title":"Incretin-based therapies for type 2 diabetes mellitus","volume":"5","author":"Lovshin","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"issue":"June (3)","key":"10.1016\/j.phrs.2018.01.013_bib0340","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11596-015-1433-2","article-title":"Review on the effect of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors for the treatment of non-alcoholic fatty liver disease","volume":"35","author":"Li","year":"2015","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"10.1016\/j.phrs.2018.01.013_bib0345","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1365-201X.1996.42256000.x","article-title":"Distribution of GLP-1 and PACAP receptors in human tissues","volume":"157","author":"Wei","year":"1996","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.phrs.2018.01.013_bib0350","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1124\/pr.108.000604","article-title":"The role of incretins in glucose homeostasis and diabetes treatment","volume":"60","author":"Kim","year":"2008","journal-title":"Pharmacol. Rev."},{"issue":"May (18)","key":"10.1016\/j.phrs.2018.01.013_bib0355","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1161\/CIRCULATIONAHA.107.739938","article-title":"Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways","volume":"117","author":"Ban","year":"2008","journal-title":"Circulation"},{"issue":"August (4)","key":"10.1016\/j.phrs.2018.01.013_bib0360","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/1755-5922.12000","article-title":"GLP-1 receptor agonists: effects on cardiovascular risk reduction","volume":"31","author":"Lorber","year":"2013","journal-title":"Cardiovasc. Ther."},{"issue":"July (7)","key":"10.1016\/j.phrs.2018.01.013_bib0365","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.21037\/jtd.2017.06.70","article-title":"Cardiovascular benefits of the newer medications for treating type 2 diabetes mellitus","volume":"9","author":"Yandrapalli","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.phrs.2018.01.013_bib0370","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev-med-050214-013431","article-title":"Cardiovascular effects of incretin-based therapies","volume":"67","author":"White","year":"2016","journal-title":"Annu. Rev. Med."},{"issue":"October (4)","key":"10.1016\/j.phrs.2018.01.013_bib0375","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.kint.2017.03.053","article-title":"The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronic kidney disease","volume":"92","author":"Tomlinson","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2018.01.013_bib0380","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2018.01.013_bib0385","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2018.01.013_bib0390","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","article-title":"Gut microbiota in cardiovascular health and disease","volume":"120","author":"Tang","year":"2017","journal-title":"Circ. Res."},{"issue":"November (6)","key":"10.1016\/j.phrs.2018.01.013_bib0395","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/HCO.0000000000000445","article-title":"Gut microbiome and its role in cardiovascular diseases","volume":"32","author":"Ahmadmehrabi","year":"2017","journal-title":"Curr. Opin. Cardiol."},{"issue":"December (12)","key":"10.1016\/j.phrs.2018.01.013_bib0400","first-page":"1700","article-title":"Trimethylamine-N-oxide: a carnitine-derived metabolite that prolongs the hypertensive effect of angiotensin II in rats","volume":"30","author":"Ufnal","year":"2014","journal-title":"Can. J. Cardiol."},{"issue":"June (19)","key":"10.1016\/j.phrs.2018.01.013_bib0405","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fped.2017.00138","article-title":"The microbiome and blood pressure: can microbes regulate our blood pressure?","volume":"5","author":"Al Khodor","year":"2017","journal-title":"Front. Pediatr."},{"issue":"Pt A","key":"10.1016\/j.phrs.2018.01.013_bib0410","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.phrs.2016.09.002","article-title":"Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension","volume":"113","author":"Weber","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2018.01.013_bib0415","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.niox.2016.09.007","article-title":"Intracolonic hydrogen sulfidelowers blood pressure in rats","volume":"60","author":"Tomasova","year":"2016","journal-title":"Nitric Oxide"},{"issue":"October (27)","key":"10.1016\/j.phrs.2018.01.013_bib0420","article-title":"Hydrogen sulfide improves endothelial dysfunction in hypertension by activating peroxisome proliferator-activated receptor delta\/endothelial nitric oxide synthase signaling","author":"Xiao","year":"2017","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2018.01.013_bib0425","doi-asserted-by":"crossref","first-page":"G1288","DOI":"10.1152\/ajpgi.00341.2012","article-title":"Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice","volume":"303","author":"Asano","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"6","key":"10.1016\/j.phrs.2018.01.013_bib0430","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.trsl.2012.12.002","article-title":"Dopamine D1 receptors mediate dopamine-induced duodenal epithelial ion transport in rats","volume":"161","author":"Feng","year":"2013","journal-title":"Transl. Res."},{"issue":"July (2)","key":"10.1016\/j.phrs.2018.01.013_bib0435","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/CIRCRESAHA.117.305853","article-title":"Involvement of bone marrow cells and neuroinflammation in hypertension","volume":"117","author":"Santisteban","year":"2015","journal-title":"Circ. Res."},{"issue":"October (25)","key":"10.1016\/j.phrs.2018.01.013_bib0440","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3389\/fphys.2017.00845","article-title":"Gut-brain axis in regulation of blood pressure","volume":"8","author":"Yang","year":"2017","journal-title":"Front. Physiol."},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2018.01.013_bib0445","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1097\/01.hjh.0000467562.03337.a5","article-title":"6b.07: hypertensive patients exhibit gut microbial dysbiosis and an increase in Th17 cells","volume":"33","author":"Kim","year":"2015","journal-title":"J. Hypertens."},{"issue":"9","key":"10.1016\/j.phrs.2018.01.013_bib0450","doi-asserted-by":"crossref","first-page":"e003698","DOI":"10.1161\/JAHA.116.003698","article-title":"Gut microbiota promote angiotensin II-induced arterial hypertension and vascular dysfunction","volume":"5","author":"Karbach","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"September (5)","key":"10.1016\/j.phrs.2018.01.013_bib0455","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/mi.2016.133","article-title":"Tryptophan metabolite activation of the aryl hydrocarbon receptor regulates IL-10 receptor expression on intestinal epithelia","volume":"10","author":"Lanis","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0460","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.cell.2016.10.020","article-title":"Linking the human gut microbiome to inflammatorycytokine production capacity","volume":"167","author":"Schirmer","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2018.01.013_bib0465","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nm.4106","article-title":"Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbonreceptor","volume":"22","author":"Rothhammer","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2018.01.013_bib0470","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signal transduction pathway","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine"},{"issue":"June (12)","key":"10.1016\/j.phrs.2018.01.013_bib0475","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1111\/bph.13117","article-title":"Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension","volume":"172","author":"Hernanz","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"June (11)","key":"10.1016\/j.phrs.2018.01.013_bib0480","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1042\/CS20110523","article-title":"Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats","volume":"122","author":"Bomfim","year":"2012","journal-title":"Clin. Sci. (Lond.)"},{"issue":"April (4)","key":"10.1016\/j.phrs.2018.01.013_bib0485","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11906-017-0734-1","article-title":"The gut, its microbiome, and hypertension","volume":"19","author":"Richards","year":"2017","journal-title":"Curr. Hypertens. Rep."},{"issue":"February","key":"10.1016\/j.phrs.2018.01.013_bib0490","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.peptides.2015.11.003","article-title":"Human gut endogenous proteins as a potential source of angiotensin-I-converting enzyme (ACE-I)-, renin inhibitory and antioxidant peptides","volume":"76","author":"Dave","year":"2016","journal-title":"Peptides"},{"key":"10.1016\/j.phrs.2018.01.013_bib0495","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1152\/physiolgenomics.00063.2015","article-title":"Historical perspective: gut dysbiosis and hypertension","volume":"46","author":"Honour","year":"2015","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.phrs.2018.01.013_bib0500","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jsbmb.2007.03.020","article-title":"Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol","volume":"104","author":"Morris","year":"2007","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"September","key":"10.1016\/j.phrs.2018.01.013_bib0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.steroids.2017.06.002","article-title":"Glucocorticoids and gut bacteria: the GALF Hypothesis in the metagenomic era","volume":"125","author":"Morris","year":"2017","journal-title":"Steroids"},{"issue":"December Suppl. 3","key":"10.1016\/j.phrs.2018.01.013_bib0510","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2362.2000.0300s3021.x","article-title":"11Beta-hydroxysteroid-dehydrogenase isoforms: tissue distribution and implications for clinical medicine","volume":"30","author":"Diederich","year":"2000","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.phrs.2018.01.013_bib0515","doi-asserted-by":"crossref","first-page":"238080","DOI":"10.1155\/2010\/238080","article-title":"Mechanisms of the regulation of the intestinal Na+\/H+ exchanger NHE3","volume":"2010","author":"He","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0520","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.1998.274.3.C586","article-title":"Aldosterone stimulates intestinal Na+ absorption in rats by increasing NHE3 expression of the proximal colon","volume":"274","author":"Cho","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"April (4)","key":"10.1016\/j.phrs.2018.01.013_bib0525","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/joim.12584","article-title":"Roles of the gut in the metabolic syndrome: an overview","volume":"281","author":"F\u00e4ndriks","year":"2017","journal-title":"J. Intern. Med."},{"issue":"5","key":"10.1016\/j.phrs.2018.01.013_bib0530","doi-asserted-by":"crossref","first-page":"G776","DOI":"10.1152\/ajpgi.00297.2001","article-title":"Intestinal NaCl transport in NHE2 and NHE3 knockout mice","volume":"282","author":"Gawenis","year":"2002","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"April (4)","key":"10.1016\/j.phrs.2018.01.013_bib0535","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11906-017-0726-1","article-title":"Gastrointestinal tract: a promising target for the management of hypertension","volume":"19","author":"Xiong","year":"2017","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.phrs.2018.01.013_bib0540","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature11228","article-title":"ACE2 links amino acid malnutrition to microbial ecology and intestinalinflammation","volume":"487","author":"Hashimoto","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2018.01.013_bib0545","doi-asserted-by":"crossref","first-page":"e0150861","DOI":"10.1371\/journal.pone.0150861","article-title":"Antiinflammatory action of angiotensin 1\u20137 in experimental colitis","volume":"11","author":"Khajah","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.01.013_bib0550","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1177\/1470320315598697","article-title":"Correlation between renin-angiotensin system gene polymorphisms and essential hypertension in the Chinese Yi ethnicgroup","volume":"16","author":"Yang","year":"2015","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"10.1016\/j.phrs.2018.01.013_bib0555","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1073\/pnas.0812874106","article-title":"Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites","volume":"106","author":"Wikoff","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2018.01.013_bib0560","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1681\/ASN.2010121220","article-title":"Colonic contribution to uremic solutes","volume":"22","author":"Aronov","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0565","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/art.1780080429","article-title":"Role of the intestinal tract in the elimination of uric acid","volume":"8","author":"Sorensen","year":"1965","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.phrs.2018.01.013_bib0570","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/bs.aambs.2016.06.002","article-title":"The role of the gut microbiome on chronic kidney disease","volume":"96","author":"Sampaio-Maia","year":"2016","journal-title":"Adv. Appl. Microbiol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0575","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJMra071313","article-title":"Uremia","volume":"357","author":"Meyer","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"June (6)","key":"10.1016\/j.phrs.2018.01.013_bib0580","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00467-016-3392-7","article-title":"Gutmicrobiome and kidney disease: a bidirectional relationship","volume":"32","author":"Al Khodor","year":"2017","journal-title":"Pediatr. Nephrol."},{"issue":"April (4)","key":"10.1016\/j.phrs.2018.01.013_bib0585","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1681\/ASN.2013080905","article-title":"The gut microbiome, kidney disease, and targeted interventions","volume":"25","author":"Ramezani","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"August (8)","key":"10.1016\/j.phrs.2018.01.013_bib0590","first-page":"608","article-title":"Pathology of gastrointestinal tract in chronic hemodialysis patients: an autopsy study of 78 cases","volume":"80","author":"Vaziri","year":"1985","journal-title":"Am. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.phrs.2018.01.013_bib0595","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/ki.2012.440","article-title":"The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease","volume":"83","author":"Anders","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2018.01.013_bib0600","doi-asserted-by":"crossref","first-page":"438e443","DOI":"10.1159\/000343886","article-title":"Uremic plasma impairs barrier function and depletes the tight junction protein constituents of intestinal epithelium","volume":"36","author":"Vaziri","year":"2012","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0605","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00240-003-0381-7","article-title":"Bacterial translocation in experimental uremia","volume":"32","author":"Almeida Duarte","year":"2004","journal-title":"Urol. Res."},{"key":"10.1016\/j.phrs.2018.01.013_bib0610","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000353764","article-title":"Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction","volume":"38","author":"Vaziri","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0615","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.3748\/wjg.v9.i11.2385","article-title":"Gut in diseases: physiological elements and their clinical significance","volume":"9","author":"Ding","year":"2003","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0620","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1128\/aem.55.3.679-683.1989","article-title":"Significance of microflora in proteolysis in the colon","volume":"55","author":"Gibson","year":"1989","journal-title":"Appl. Environ. Microbiol."},{"issue":"November (6)","key":"10.1016\/j.phrs.2018.01.013_bib0625","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1053\/j.jrn.2017.02.010","article-title":"The leaky gut and altered microbiome in chronic kidney disease","volume":"27","author":"Lau","year":"2017","journal-title":"J. Ren. Nutr."},{"key":"10.1016\/j.phrs.2018.01.013_bib0630","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1007\/s10620-012-2242-0","article-title":"Gut bacterial translocation contributes to microinflammation in experimental uremia","volume":"57","author":"Wang","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.phrs.2018.01.013_bib0635","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000186158","article-title":"Increased intestinal permeability to differently sized polyethylene glycols in uremic rats: effects of low- and high-protein diets","volume":"56","author":"Magnusson","year":"1990","journal-title":"Nephron"},{"key":"10.1016\/j.phrs.2018.01.013_bib0640","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1159\/000351171","article-title":"Oral activated charcoal adsorbent (AST-120) ameliorates CKD-induced intestinal epithelial barrier disruption and systemic inflammation","volume":"37","author":"Vaziri","year":"2013","journal-title":"Am. J. Nephrol."},{"issue":"June (6)","key":"10.1016\/j.phrs.2018.01.013_bib0645","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1038\/cti.2016.36","article-title":"The microbiota and chronickidneydiseases: a double-edged sword","volume":"5","author":"Felizardo","year":"2016","journal-title":"Clin. Transl. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2018.01.013_bib0650","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/ki.2012.440","article-title":"The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease","volume":"83","author":"Anders","year":"2013","journal-title":"Kidney Int."},{"issue":"April (4)","key":"10.1016\/j.phrs.2018.01.013_bib0655","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1113\/EP085283","article-title":"Gutmicrobiome in chronic kidney disease","volume":"101","author":"Wing","year":"2016","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0660","doi-asserted-by":"crossref","first-page":"e37584","DOI":"10.1371\/journal.pone.0037584","article-title":"TLR2, TLR4 and the MYD88 signaling pathway are crucial for neutrophil migration in acute kidney injury induced by sepsis","volume":"7","author":"Castoldi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.01.013_bib0665","doi-asserted-by":"crossref","first-page":"e29004","DOI":"10.1371\/journal.pone.0029004","article-title":"Pivotal role of Toll-like receptors 2 and 4, its adaptor molecule MyD88, and inflammasome complex in experimental tubule-interstitial nephritis","volume":"6","author":"Correa-Costa","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.01.013_bib0670","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.2119\/molmed.2012.00131","article-title":"MyD88 signaling pathway is involved in renal fibrosis by favoring a TH2 immune response and activating alternative M2 macrophages","volume":"18","author":"Braga","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.phrs.2018.01.013_bib0675","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.4049\/jimmunol.168.3.1286","article-title":"In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNFalpha mediated up-regulation during inflammation","volume":"168","author":"Wolfs","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0680","doi-asserted-by":"crossref","first-page":"640e653","DOI":"10.1093\/oxfordjournals.molbev.a004123","article-title":"Loss of urate oxidase activity in hominoids and its evolutionary implications","volume":"19","author":"Oda","year":"2002","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0685","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000360010","article-title":"Expansion of urease- and uricasecontaining, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD","volume":"39","author":"Wong","year":"2014","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0690","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/jps.22592","article-title":"Update on the pharmacokinetics and redox properties of protein-bound uremic toxins","volume":"100","author":"Watanabe","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.phrs.2018.01.013_bib0695","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1097\/01.ASN.0000022017.96399.B2","article-title":"Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity","volume":"13","author":"Enomoto","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0700","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1159\/000074327","article-title":"Uremic toxins overload accelerates renal damage in a rat model of chronic renal failure","volume":"95","author":"Satoh","year":"2003","journal-title":"Nephron Exp. Nephrol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0705","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0710","first-page":"S15","article-title":"Indoxyl sulfate increases the gene expressions of TGF-beta 1, TIMP-1 and pro-alpha 1(I) collagen in uremic rat kidneys","volume":"62","author":"Miyazaki","year":"1997","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.phrs.2018.01.013_bib0715","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2215\/CJN.07971109","article-title":"P-Cresol and cardiovascular risk in mild-to-moderate kidney disease","volume":"5","author":"Meijers","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0720","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.ki.5000115","article-title":"Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients","volume":"69","author":"Bammens","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2018.01.013_bib0725","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/ki.2012.448","article-title":"p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADpH oxidase","volume":"83","author":"Watanabe","year":"2013","journal-title":"Kidney Int."},{"issue":"October (1)","key":"10.1016\/j.phrs.2018.01.013_bib0730","doi-asserted-by":"crossref","first-page":"13781","DOI":"10.1038\/s41598-017-13739-9","article-title":"TMAO is associated with mortality: impact of modestly impaired renal function","volume":"7","author":"Gruppen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2018.01.013_bib0735","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ. Res."},{"issue":"November (2)","key":"10.1016\/j.phrs.2018.01.013_bib0740","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.bbrc.2017.09.108","article-title":"Gut microbial metabolite TMAO contributes to renal dysfunction in a mouse model of diet-induced obesity","volume":"493","author":"Sun","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.phrs.2018.01.013_bib0745","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.kint.2016.06.033","article-title":"Gutmicrobiota in renalphysiology: focus on short-chain fattyacids and their receptors","volume":"90","author":"Pluznick","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2018.01.013_bib0750","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.phrs.2018.01.013_bib0755","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1073\/pnas.1322269111","article-title":"The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition","volume":"111","author":"Chang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2018.01.013_bib0760","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1097\/MCG.0b013e31822fecfe","article-title":"Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics","volume":"45","author":"Macfarlane","year":"2011","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0765","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1172\/JCI103940","article-title":"Urea metabolism in man","volume":"38","author":"Walser","year":"1959","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2018.01.013_bib0770","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000185328","article-title":"Comparison of toxic effects of methylguanidine, guanidinosuccinic acid and creatinine in rats with adenine-induced chronic renal failure","volume":"51","author":"Yokozawa","year":"1989","journal-title":"Nephron"},{"key":"10.1016\/j.phrs.2018.01.013_bib0775","first-page":"608","article-title":"Pathology of gastrointestinal tract in chronic hemodialysis patients: an autopsy study of 78 cases","volume":"80","author":"Vaziri","year":"1985","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0780","first-page":"198","article-title":"The conversion of creatinine by creatininase of bacterial origin","volume":"34","author":"Eyk","year":"1968","journal-title":"Enzymologia"},{"key":"10.1016\/j.phrs.2018.01.013_bib0785","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0002-9343(51)90218-5","article-title":"Blood levels of urea nitrogen, phenol, guanidine and creatinine in uremia","volume":"10","author":"Olsen","year":"1951","journal-title":"Am. J. Med."},{"key":"10.1016\/j.phrs.2018.01.013_bib0790","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/ki.2013.449","article-title":"Hydrogen sulfide inhibits the renal fibrosis of obstructive nephropathy","volume":"85","author":"Song","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2018.01.013_bib0795","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000321838","article-title":"Hydrogen sulfide, a toxic gas with cardiovascular properties in uremia: how harmful is it?","volume":"31","author":"Perna","year":"2011","journal-title":"Blood Purif."},{"key":"10.1016\/j.phrs.2018.01.013_bib0800","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/labinvest.2011.114","article-title":"Indoxyl sulfate, a representative uremic toxin, suppresses erythropoietin production in a HIF-dependent manner","volume":"91","author":"Chiang","year":"2011","journal-title":"Lab. Invest."},{"key":"10.1016\/j.phrs.2018.01.013_bib0805","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1086\/523341","article-title":"Probiotics: definition, sources, selection, and uses","volume":"46","author":"Sanders","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"April (4)","key":"10.1016\/j.phrs.2018.01.013_bib0810","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11906-017-0723-4","article-title":"Antihypertensive effects of probiotics","volume":"19","author":"Robles-Vera","year":"2017","journal-title":"Curr. Hypertens. Rep."},{"issue":"April (26)","key":"10.1016\/j.phrs.2018.01.013_bib0815","first-page":"578","article-title":"Functional properties of microorganisms in fermented foods","volume":"7","author":"Tamang","year":"2016","journal-title":"Front. Microbiol."},{"issue":"8","key":"10.1016\/j.phrs.2018.01.013_bib0820","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2174\/1389450115666140606111402","article-title":"Therapeutic modulation of gut microbiota: current clinical applications and future perspectives","volume":"15","author":"Ianiro","year":"2014","journal-title":"Curr. Drug Targets"},{"issue":"November (5)","key":"10.1016\/j.phrs.2018.01.013_bib0825","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/ki.2015.255","article-title":"Probiotics and chronic kidney disease","volume":"88","author":"Koppe","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2018.01.013_bib0830","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1022993905778","article-title":"Lactic acid bacteria: inhibition of angiotensin converting enzyme in vitro and in vivo","volume":"83","author":"Fuglsang","year":"2003","journal-title":"Antonie Van Leeuwenhoek"},{"key":"10.1016\/j.phrs.2018.01.013_bib0835","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1271\/bbb.60.488","article-title":"Decrease of tissue angiotensin I-converting enzyme activity upon feeding sour milk in spontaneously hypertensive rats","volume":"60","author":"Nakamura","year":"1996","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.phrs.2018.01.013_bib0840","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3389\/fphys.2016.00448","article-title":"New insights on the use of dietary polyphenols or probiotics for the management of arterial hypertension","volume":"7","author":"de Brito Alves","year":"2016","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0845","doi-asserted-by":"crossref","first-page":"798S","DOI":"10.1093\/jn\/137.3.798S","article-title":"Intestinal microflora: probiotics and autoimmunity","volume":"137","author":"Matsuzaki","year":"2007","journal-title":"J. Nutr."},{"issue":"December (21)","key":"10.1016\/j.phrs.2018.01.013_bib0850","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12934-015-0394-2","article-title":"Effective treatment of hypertension by recombinant Lactobacillus plantarum expressing angiotensin converting enzyme inhibitory peptide","volume":"14","author":"Yang","year":"2015","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.phrs.2018.01.013_bib0855","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1042\/CS20130339","article-title":"The probiotic Lactobacillus coryniformis CECT5711 reduces the vascular pro-oxidant and proinflammatory status in obese mice","volume":"127","author":"Toral","year":"2014","journal-title":"Clin. Sci. (Lond.)"},{"issue":"October (16)","key":"10.1016\/j.phrs.2018.01.013_bib0860","article-title":"Lactobacillus rhamnosus L34 attenuates gut translocation induced bacterial sepsis in murine models of leaky gut","author":"Panpetch","year":"2017","journal-title":"Infect. Immun."},{"issue":"September (1)","key":"10.1016\/j.phrs.2018.01.013_bib0865","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.atherosclerosis.2015.05.005","article-title":"Effect of Lactobacillus casei Shirota supplementation on trimethylamine-N-oxide levels in patients with metabolic syndrome: an open-label, randomized study","volume":"242","author":"Tripolt","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2018.01.013_bib0870","doi-asserted-by":"crossref","first-page":"621","DOI":"10.4196\/kjpp.2016.20.6.621","article-title":"Lactobacillus casei strain C1 attenuates vascular changes in spontaneously hypertensive rats","volume":"20","author":"Yap","year":"2016","journal-title":"Korean J. Physiol. Pharmacol."},{"issue":"November (11)","key":"10.1016\/j.phrs.2018.01.013_bib0875","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1002\/mnfr.201500290","article-title":"Antihypertensive effects of probiotics Lactobacillus strains in spontaneously hypertensive rats","volume":"59","author":"G\u00f3mez-Guzm\u00e1n","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"issue":"August (35)","key":"10.1016\/j.phrs.2018.01.013_bib0880","doi-asserted-by":"crossref","first-page":"25088","DOI":"10.1074\/jbc.M113.452516","article-title":"Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion","volume":"288","author":"Yadav","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"June (2)","key":"10.1016\/j.phrs.2018.01.013_bib0885","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12602-016-9241-y","article-title":"Current perspectives on antihypertensive probiotics","volume":"9","author":"Daliri","year":"2017","journal-title":"Probiotics Antimicrob. Proteins"},{"issue":"November (1)","key":"10.1016\/j.phrs.2018.01.013_bib0890","article-title":"Gut microbiota and hypertension: from pathogenesis to new therapeutic strategies","author":"Kang","year":"2017","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.phrs.2018.01.013_bib0895","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/ajcn\/64.5.767","article-title":"A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects","volume":"64","author":"Hata","year":"1996","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2018.01.013_bib0900","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/07315724.2005.10719473","article-title":"Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension","volume":"24","author":"Aihara","year":"2005","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.phrs.2018.01.013_bib0905","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ajcn\/77.2.326","article-title":"A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects","volume":"77","author":"Seppo","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"issue":"February (1)","key":"10.1016\/j.phrs.2018.01.013_bib0910","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3920\/BM2016.0135","article-title":"Habitual intake of fermented milk products containing Lactobacillus casei strain Shirota and a reduced risk of hypertension in older people","volume":"8","author":"Aoyagi","year":"2017","journal-title":"Benef. Microbes"},{"key":"10.1016\/j.phrs.2018.01.013_bib0915","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/HYPERTENSIONAHA.114.03469","article-title":"Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized,controlled trials","volume":"64","author":"Khalesi","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2018.01.013_bib0920","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1017\/S0007114513001712","article-title":"Effect of probiotic fermented milk on blood pressure: a meta-analysis of randomised controlled trials","volume":"110","author":"Dong","year":"2013","journal-title":"Br. J. Nutr."},{"issue":"May (11)","key":"10.1016\/j.phrs.2018.01.013_bib0925","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/CIRCRESAHA.117.310734","article-title":"Gut microbiota: potential for a unifying hypothesis for prevention and treatment of hypertension","volume":"120","author":"Qi","year":"2017","journal-title":"Circ. Res."},{"issue":"April (4)","key":"10.1016\/j.phrs.2018.01.013_bib0930","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1039\/C5FO00950B","article-title":"Dietary fiber and blood pressure control","volume":"7","author":"Aleixandre","year":"2016","journal-title":"Food Funct."},{"issue":"4","key":"10.1016\/j.phrs.2018.01.013_bib0935","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.amjcard.2009.10.002","article-title":"A further subgroup analysis of the effects of the DASH diet and three dietary sodium levels on blood pressure: results of the DASH- sodium trial (vol 94, pg 222, 2004)","volume":"105","author":"Bray","year":"2010","journal-title":"Am. J. Cardiol."},{"issue":"7599","key":"10.1016\/j.phrs.2018.01.013_bib0940","doi-asserted-by":"crossref","first-page":"885b","DOI":"10.1136\/bmj.39147.604896.55","article-title":"Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)","volume":"334","author":"Cook","year":"2007","journal-title":"Br. Med. J."},{"key":"10.1016\/j.phrs.2018.01.013_bib0945","doi-asserted-by":"crossref","first-page":"830S","DOI":"10.1093\/jn\/137.3.830S","article-title":"Prebiotics: the concept revisited","volume":"137","author":"Roberfroid","year":"2007","journal-title":"J. Nutr."},{"issue":"6","key":"10.1016\/j.phrs.2018.01.013_bib0950","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/ajcn\/82.6.1185","article-title":"Dietary fiber intake and risk factors for cardiovascular disease in French adults","volume":"82","author":"Lairon","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"issue":"August (8)","key":"10.1016\/j.phrs.2018.01.013_bib0955","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.3390\/ijms10083517","article-title":"Antihypertensive properties of plant-based prebiotics","volume":"10","author":"Yeo","year":"2009","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2018.01.013_bib0960","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1017\/S0007114511003163","article-title":"Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR:LA-cp rats","volume":"107","author":"Parnell","year":"2012","journal-title":"Br. J. Nutr."},{"issue":"October (25)","key":"10.1016\/j.phrs.2018.01.013_bib0965","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13578-017-0183-1","article-title":"Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics","volume":"7","author":"He","year":"2017","journal-title":"Cell Biosci."},{"issue":"6","key":"10.1016\/j.phrs.2018.01.013_bib0970","first-page":"475","article-title":"Systemic inflammatory markers in older persons: the effect of oral nutritional supplementation with prebiotics","volume":"11","author":"Schiffrin","year":"2007","journal-title":"J. Nutr. Health Aging"},{"issue":"5","key":"10.1016\/j.phrs.2018.01.013_bib0975","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3945\/ajcn.2009.28095","article-title":"Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal","volume":"90","author":"Cani","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2018.01.013_bib0980","first-page":"129","article-title":"High molecular weight barley beta-glucan alters gut microbiota toward reduced cardiovascular disease risk","volume":"7","author":"Wang","year":"2016","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.phrs.2018.01.013_bib0985","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/archinte.165.2.150","article-title":"Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials","volume":"165","author":"Streppel","year":"2005","journal-title":"Arch. Intern. Med."},{"issue":"3","key":"10.1016\/j.phrs.2018.01.013_bib0990","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5946\/ce.2015.117","article-title":"Fecal microbiota transplantation: current applications, effectiveness, and future perspectives","volume":"49","author":"Choi","year":"2016","journal-title":"Clin. Endosc."},{"issue":"Summer (2)","key":"10.1016\/j.phrs.2018.01.013_bib0995","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1755-5922.2009.00077.x","article-title":"Innate immunity and toll-like receptor antagonists: a potential role in the treatment of cardiovascular diseases","volume":"27","author":"Lin","year":"2009","journal-title":"Cardiovasc. Ther."},{"issue":"July (8)","key":"10.1016\/j.phrs.2018.01.013_bib1000","article-title":"Computational approaches to toll-like receptor 4 modulation","volume":"21","author":"Billod","year":"2016","journal-title":"Molecules"},{"issue":"August (8)","key":"10.1016\/j.phrs.2018.01.013_bib1005","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/CCM.0b013e3181e7c5c9","article-title":"A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis","volume":"38","author":"Rice","year":"2010","journal-title":"Crit. Care Med."},{"issue":"March (11)","key":"10.1016\/j.phrs.2018.01.013_bib1010","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jama.2013.2194","article-title":"Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial","volume":"309","author":"Opal","year":"2013","journal-title":"JAMA"},{"issue":"April (4)","key":"10.1016\/j.phrs.2018.01.013_bib1015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1517\/17425255.2011.558190","article-title":"Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies","volume":"7","author":"Barochia","year":"2011","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"October (5)","key":"10.1016\/j.phrs.2018.01.013_bib1020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejphar.2017.07.012","article-title":"JKB-122 is effective, alone or in combination with prednisolone in Con A-induced hepatitis","volume":"812","author":"Hsu","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"July (7)","key":"10.1016\/j.phrs.2018.01.013_bib1025","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.cgh.2016.08.002","article-title":"New pharmacologic agents that target inflammation and fibrosis in nonalcoholic steatohepatitis-related kidney disease","volume":"15","author":"Musso","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"November (11)","key":"10.1016\/j.phrs.2018.01.013_bib1030","doi-asserted-by":"crossref","first-page":"e0142456","DOI":"10.1371\/journal.pone.0142456","article-title":"TAK-242, a toll-like receptor 4 antagonist, protects against aldosterone-induced cardiac and renal injury","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.01.013_bib1035","doi-asserted-by":"crossref","first-page":"427640","DOI":"10.1155\/2013\/427640","article-title":"Chronic inhibition of 11 \u03b2 \u2013 hydroxysteroid dehydrogenase type 1 activity decreases hypertension, insulin resistance, and hypertriglyceridemia in metabolic syndrome","volume":"2013","author":"Schnackenberg","year":"2013","journal-title":"Biomed Res. Int."},{"issue":"October (10)","key":"10.1016\/j.phrs.2018.01.013_bib1040","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1463-1326.2012.01582.x","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus","volume":"14","author":"Pereira","year":"2012","journal-title":"Diabetes Obes. Metab."},{"issue":"January (1)","key":"10.1016\/j.phrs.2018.01.013_bib1045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.metabol.2012.05.002","article-title":"11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?","volume":"62","author":"Anagnostis","year":"2013","journal-title":"Metabolism"},{"issue":"October (4)","key":"10.1016\/j.phrs.2018.01.013_bib1050","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.amjms.2017.03.023","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 in obese subjects with type 2 diabetes mellitus","volume":"354","author":"Li","year":"2017","journal-title":"Am. J. Med. Sci."},{"issue":"August (4)","key":"10.1016\/j.phrs.2018.01.013_bib1055","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/er.2012-1050","article-title":"11\u03b2-Hydroxysteroid dehydrogenase 1: translational and therapeutic aspects","volume":"34","author":"Gathercole","year":"2013","journal-title":"Endocr. Rev."},{"issue":"September (9)","key":"10.1016\/j.phrs.2018.01.013_bib1060","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.2196\/resprot.7806","article-title":"Assessing the efficacy and safety of an 11\u03b2-Hydroxysteroid dehydrogenase type 1 inhibitor (AZD4017) in the idiopathic intracranial hypertension drug trial, IIH:DT: clinical methods and design for a phase II randomized controlled trial","volume":"6","author":"Markey","year":"2017","journal-title":"JMIR Res. Protoc."},{"issue":"June (12)","key":"10.1016\/j.phrs.2018.01.013_bib1065","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1016\/j.bmcl.2013.03.011","article-title":"Evaluation of selective inhibitors of 11\u03b2-HSD1 for the treatment of hypertension","volume":"23","author":"Bauman","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"May\u2013June (3)","key":"10.1016\/j.phrs.2018.01.013_bib1070","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jash.2011.01.009","article-title":"Efficacy and safety of the selective 11\u03b2-HSD-1 inhibitors MK-0736 and MK-0916 in overweight and obese patients with hypertension","volume":"5","author":"Shah","year":"2011","journal-title":"J. Am. Soc. Hypertens."},{"issue":"May (5)","key":"10.1016\/j.phrs.2018.01.013_bib1075","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/ajg.2017.41","article-title":"Tenapanor treatment of patients with constipation-predominant irritable bowel syndrome: a phase 2, randomized, placebo-controlled efficacy and safety trial","volume":"112","author":"Chey","year":"2017","journal-title":"Am. J. Gastroenterol."},{"issue":"June (6)","key":"10.1016\/j.phrs.2018.01.013_bib1080","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1681\/ASN.2016080855","article-title":"Effect of tenapanor on serum phosphate in patients receiving hemodialysis","volume":"28","author":"Block","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.phrs.2018.01.013_bib1085","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1161\/HYPERTENSIONAHA.112.201590","article-title":"Antihypertensive and laxative effects by pharmacological inhibition of sodium-protonexchanger subtype 3-mediated sodium absorption in the gut","volume":"60","author":"Linz","year":"2012","journal-title":"Hypertension"},{"issue":"March (3)","key":"10.1016\/j.phrs.2018.01.013_bib1090","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/FJC.0000000000000336","article-title":"Inhibition of NHE3-mediated sodium absorption in the gut reduced cardiac end-organ damage without deteriorating renal function in obese spontaneously hypertensive rats","volume":"67","author":"Linz","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2018.01.013_bib1095","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/MNH.0000000000000154","article-title":"Pharmacologic inhibition of intestinal sodium uptake: a gut centric approach to sodium management","volume":"24","author":"Spencer","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"October (11)","key":"10.1016\/j.phrs.2018.01.013_bib1100","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrcardio.2017.159","article-title":"Gastrointestinal sodium absorption, microbiome, and hypertension","volume":"14","author":"Mishima","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"issue":"November (8)","key":"10.1016\/j.phrs.2018.01.013_bib1105","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.tcm.2016.05.004","article-title":"Emerging concepts for patients with treatment-resistant hypertension","volume":"26","author":"Eirin","year":"2016","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.phrs.2018.01.013_bib1110","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(09)61500-2","article-title":"A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial","volume":"374","author":"Weber","year":"2009","journal-title":"Lancet"},{"issue":"October (4)","key":"10.1016\/j.phrs.2018.01.013_bib1115","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"June (3)","key":"10.1016\/j.phrs.2018.01.013_bib1120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/08037051.2016.1208730","article-title":"Endothelin-receptor antagonist can reduce blood pressure in patients with hypertension: a meta-analysis","volume":"26","author":"Yuan","year":"2017","journal-title":"Blood Press."},{"issue":"January (1)","key":"10.1016\/j.phrs.2018.01.013_bib1125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4158\/EP151126.CS","article-title":"Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management ALGORITHM\u20142016 executive summary","volume":"22","author":"Garber","year":"2016","journal-title":"Endocr. Pract."},{"issue":"September (3)","key":"10.1016\/j.phrs.2018.01.013_bib1130","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.112.195115","article-title":"Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism","volume":"60","author":"Liu","year":"2012","journal-title":"Hypertension"},{"issue":"February (2)","key":"10.1016\/j.phrs.2018.01.013_bib1135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11906-015-0621-6","article-title":"GLP-1 agonists and blood pressure a review of the evidence","volume":"18","author":"Goud","year":"2016","journal-title":"Curr. Hypertens. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2018.01.013_bib1140","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/HYPERTENSIONAHA.114.04718","article-title":"Glucagon-like peptide-1 and blood pressure in young and healthy adults from the general population","volume":"65","author":"Krisai","year":"2015","journal-title":"Hypertension"},{"issue":"August (8)","key":"10.1016\/j.phrs.2018.01.013_bib1145","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/dom.12085","article-title":"Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials","volume":"15","author":"Wang","year":"2013","journal-title":"Diabetes Obes. Metab."},{"issue":"January (1)","key":"10.1016\/j.phrs.2018.01.013_bib1150","article-title":"Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysis","volume":"3","author":"Robinson","year":"2013","journal-title":"BMJ Open"},{"issue":"October (1)","key":"10.1016\/j.phrs.2018.01.013_bib1155","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.diabres.2015.07.015","article-title":"Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: a systematic review and network meta-analysis","volume":"110","author":"Sun","year":"2015","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"February (2)","key":"10.1016\/j.phrs.2018.01.013_bib1160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1620\/tjem.223.133","article-title":"Sitagliptin, a dipeptidyl peptidase-4 inhibitor, decreases systolic blood pressure in Japanese hypertensive patients with type 2 diabetes","volume":"223","author":"Ogawa","year":"2011","journal-title":"Tohoku J. Exp. Med."},{"issue":"May (5)","key":"10.1016\/j.phrs.2018.01.013_bib1165","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/0091270008316885","article-title":"Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension","volume":"48","author":"Mistry","year":"2008","journal-title":"J. Clin. Pharmacol."},{"issue":"September (10)","key":"10.1016\/j.phrs.2018.01.013_bib1170","article-title":"Effects of antidiabetic drugs on gut microbiota composition","volume":"8","author":"Montandon","year":"2017","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.phrs.2018.01.013_bib1175","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2093171","article-title":"Microflora disturbance during progression of glucose intolerance and effect of sitagliptin: an animal study","volume":"2016","author":"Yan","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.phrs.2018.01.013_bib1180","article-title":"Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatment","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.phrs.2018.01.013_bib1185","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1292\/jvms.14-0191","article-title":"Regulation of epithelial cell tight junctions by protease-activated receptor 2","volume":"76","author":"Enjoji","year":"2014","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.phrs.2018.01.013_bib1190","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1146\/annurev-physiol-021113-170317","article-title":"Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2","volume":"76","author":"Drucker","year":"2014","journal-title":"Annu. Rev. Physiol."},{"issue":"9","key":"10.1016\/j.phrs.2018.01.013_bib1195","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.bbadis.2014.06.004","article-title":"Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2","volume":"1842","author":"Wronkowitz","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"October (10)","key":"10.1016\/j.phrs.2018.01.013_bib1200","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1139\/cjpp-2014-0493","article-title":"Minocycline: a bacteriostatic antibiotic with pleiotropic cardioprotective effects","volume":"93","author":"Brenes-Salazar","year":"2015","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.phrs.2018.01.013_bib1205","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0005-2728(99)00020-1","article-title":"Nitric oxide metabolism and breakdown","volume":"1411","author":"Kelm","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2018.01.013_bib1210","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1146\/annurev.ph.57.030195.004011","article-title":"Nitric oxide in the regulation of blood flow and arterial pressure","volume":"57","author":"Umans","year":"1995","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.phrs.2018.01.013_bib1215","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3920\/BM2014.0088","article-title":"The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial","volume":"6","author":"Wang","year":"2015","journal-title":"Benef. Microbes"},{"key":"10.1016\/j.phrs.2018.01.013_bib1220","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12937-016-0127-3","article-title":"Association between probiotic and yogurt consumption and kidney disease: insights from NHANES","volume":"15","author":"Yacoub","year":"2016","journal-title":"Nutr. J."},{"key":"10.1016\/j.phrs.2018.01.013_bib1225","doi-asserted-by":"crossref","first-page":"568571","DOI":"10.1155\/2014\/568571","article-title":"Randomized controlled trial of strain-specific probiotic formulation (Renadyl) in dialysis patients","volume":"2014","author":"Natarajan","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"9","key":"10.1016\/j.phrs.2018.01.013_bib1230","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s12325-010-0059-9","article-title":"Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease","volume":"27","author":"Ranganathan","year":"2010","journal-title":"Adv. Ther."},{"issue":"September (6)","key":"10.1016\/j.phrs.2018.01.013_bib1235","article-title":"Probiotic supplementation in chronic kidney disease: a double-blind, randomized, placebo-controlled trial","author":"Borges","year":"2017","journal-title":"J. Ren. Nutr."},{"key":"10.1016\/j.phrs.2018.01.013_bib1240","doi-asserted-by":"crossref","first-page":"10431049","DOI":"10.1016\/j.numecd.2014.04.007","article-title":"Effect of short-term synbiotic treatment on plasma p-cresol levels in patients with chronic renal failure: a randomized clinical trial","volume":"24","author":"Guida","year":"2014","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.phrs.2018.01.013_bib1245","doi-asserted-by":"crossref","first-page":"11821189","DOI":"10.2215\/CJN.07971109","article-title":"p-Cresol and cardiovascular risk inmild-to-moderate kidney disease","volume":"5","author":"Meijers","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2018.01.013_bib1250","doi-asserted-by":"crossref","first-page":"16031610","DOI":"10.2215\/CJN.00490114","article-title":"Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients","volume":"9","author":"Sirich","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2018.01.013_bib1255","doi-asserted-by":"crossref","first-page":"e114881","DOI":"10.1371\/journal.pone.0114881","article-title":"High amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney disease","volume":"9","author":"Vaziri","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.01.013_bib1260","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/01.ta.0000196574.70614.27","article-title":"The role of Bifidobacteria in gut barrier function after thermal injury in rats","volume":"61","author":"Wang","year":"2006","journal-title":"J. Trauma"},{"key":"10.1016\/j.phrs.2018.01.013_bib1265","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/gut.2008.165886","article-title":"Changes in gut microbiota control inflammation in obese mice through amechanism involving GLP-2-driven improvement of gut permeability","volume":"58","author":"Cani","year":"2009","journal-title":"Gut"},{"issue":"November","key":"10.1016\/j.phrs.2018.01.013_bib1270","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2217\/fmb-2017-0059","article-title":"Short-chain fatty acids: a link between prebiotics and microbiota in chronic kidney disease","volume":"12","author":"Esgalhado","year":"2017","journal-title":"Future Microbiol."},{"key":"10.1016\/j.phrs.2018.01.013_bib1275","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ejcn.2014.237","article-title":"Dietary fiber effects in chronic kidney disease: a systematic review and meta-analysis of controlled feeding trials","volume":"69","author":"Chiavaroli","year":"2015","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2018.01.013_bib1280","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1681\/ASN.2010111196","article-title":"Valproic acid attenuates proteinuria and kidney injury","volume":"22","author":"Van Beneden","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2018.01.013_bib1285","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1681\/ASN.2014030288","article-title":"Gut bacteria products prevent AKI induced by ischemia-reperfusion","volume":"26","author":"Andrade-Oliveira","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2018.01.013_bib1290","doi-asserted-by":"crossref","first-page":"10431049","DOI":"10.1016\/j.numecd.2014.04.007","article-title":"Effect of short-term synbiotic treatment on plasma p-cresol levels in patients with chronic renal failure: a randomized clinical trial","volume":"24","author":"Guida","year":"2014","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"2","key":"10.1016\/j.phrs.2018.01.013_bib1295","first-page":"222","article-title":"Influence of prebiotic and probiotic supplementation on the progression of chronic kidney disease","volume":"68","author":"Pavan","year":"2016","journal-title":"Minerva Urol. Nefrol."},{"key":"10.1016\/j.phrs.2018.01.013_bib1300","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.05240515","article-title":"Synbiotics easing renal failure by improving gut microbiology (SYNERGY): a randomized trial","volume":"11","author":"Rossi","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"May (3)","key":"10.1016\/j.phrs.2018.01.013_bib1305","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1053\/j.jrn.2014.09.008","article-title":"Effect of a symbiotic gel (Lactobacillus acidophilus\u202f+\u202fBifidobacterium lactis\u202f+\u202finulin) on presence and severity of gastrointestinal symptoms in hemodialysis patients","volume":"25","author":"Viramontes-H\u00f6rner","year":"2015","journal-title":"J. Ren. Nutr."},{"key":"10.1016\/j.phrs.2018.01.013_bib1310","doi-asserted-by":"crossref","first-page":"192e198","DOI":"10.1038\/sj.ki.5001523","article-title":"Acarbose treatment lowers generation and serum concentrations of the protein-bound solute p-cresol: a pilot study","volume":"70","author":"Evenepoel","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2018.01.013_bib1315","unstructured":"Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Sep. CADTH Rapid Response Reports. Sevelamer for the Treatment of Patients with Chronic Kidney Disease: A Review of Clinical and Cost-Effectiveness."},{"issue":"December (6)","key":"10.1016\/j.phrs.2018.01.013_bib1320","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/1753944713513061","article-title":"Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease","volume":"7","author":"Rastogi","year":"2013","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"10.1016\/j.phrs.2018.01.013_bib1325","doi-asserted-by":"crossref","first-page":"22722279","DOI":"10.2215\/CJN.01650211","article-title":"Effect of phosphate binders on serum inflammatory profile, soluble CD14, and endotoxin levels in hemodialysis patients","volume":"6","author":"Navarro-Gonzalez","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"November (20)","key":"10.1016\/j.phrs.2018.01.013_bib1330","article-title":"Plasma p-cresol lowering effect of sevelamer in non-dialysis CKD patients: evidence from a randomized controlled trial","author":"Riccio","year":"2017","journal-title":"Clin. Exp. Nephrol."},{"issue":"April (4)","key":"10.1016\/j.phrs.2018.01.013_bib1335","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/01.mcg.0000225665.68920.df","article-title":"Lubiprostone: a chloride channel activator","volume":"41","author":"Lacy","year":"2007","journal-title":"J. Clin. Gastroenterol."},{"issue":"August (8)","key":"10.1016\/j.phrs.2018.01.013_bib1340","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1681\/ASN.2014060530","article-title":"Alteration of the intestinal environment by lubiprostone is associated with amelioration of adenine-induced CKD","volume":"26","author":"Mishima","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"January (1)","key":"10.1016\/j.phrs.2018.01.013_bib1345","doi-asserted-by":"crossref","first-page":"e0141738","DOI":"10.1371\/journal.pone.0141738","article-title":"Serum trimethylamine-N-oxide is strongly related to renal function and predicts outcome in chronic kidney disease","volume":"11","author":"Missailidis","year":"2016","journal-title":"PLoS One"},{"issue":"October (4)","key":"10.1016\/j.phrs.2018.01.013_bib1350","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.kint.2017.03.053","article-title":"The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronic kidney disease","volume":"92","author":"Tomlinson","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2018.01.013_bib1355","doi-asserted-by":"crossref","first-page":"15851595","DOI":"10.1016\/j.cell.2015.11.055","article-title":"Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis","volume":"163","author":"Wang","year":"2015","journal-title":"Cell"},{"issue":"August (8)","key":"10.1016\/j.phrs.2018.01.013_bib1360","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0090-9556(24)15166-5","article-title":"Concurrent flavin-containing monooxygenase down-regulation and cytochrome P-450 induction by dietary indoles in rat: implications for drug\u2013drug interaction","volume":"28","author":"Katchamart","year":"2000","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.phrs.2018.01.013_bib1365","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s00134-017-4832-y","article-title":"Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017: Expert opinion of the Working Group on Prevention, AKI, section, European Society of Intensive Care Medicine","volume":"43","author":"Joannidis","year":"2017","journal-title":"Intensive Care Med."},{"issue":"June (5)","key":"10.1016\/j.phrs.2018.01.013_bib1370","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.transproceed.2010.03.133","article-title":"Protective effects of Toll-like receptor 4 inhibitor eritoran on renal ischemia-reperfusion injury","volume":"42","author":"Liu","year":"2010","journal-title":"Transplant. Proc."},{"issue":"November (20)","key":"10.1016\/j.phrs.2018.01.013_bib1375","doi-asserted-by":"crossref","first-page":"16849","DOI":"10.1038\/srep16849","article-title":"Dexmedetomidine inhibits TLR4\/NF-\u03baB activation and reduces acute kidney injury after orthotopic autologous liver transplantation in rats","volume":"5","author":"Yao","year":"2015","journal-title":"Sci. Rep."},{"issue":"March (13)","key":"10.1016\/j.phrs.2018.01.013_bib1380","doi-asserted-by":"crossref","first-page":"21044","DOI":"10.18632\/oncotarget.15483","article-title":"Relaxin abrogates renal interstitial fibrosis by regulating macrophage polarization via inhibition of Toll-like receptor 4 signaling","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"April (4)","key":"10.1016\/j.phrs.2018.01.013_bib1385","doi-asserted-by":"crossref","first-page":"F661","DOI":"10.1152\/ajprenal.00316.2016","article-title":"Diabetes, hypertension, and chronic kidney disease progression: role of DPP4","volume":"312","author":"Nistala","year":"2017","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"October (4)","key":"10.1016\/j.phrs.2018.01.013_bib1390","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/ki.2014.236","article-title":"The potential for renoprotection with incretin-based drugs","volume":"86","author":"Tanaka","year":"2014","journal-title":"Kidney Int."},{"issue":"March (3)","key":"10.1016\/j.phrs.2018.01.013_bib1395","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ki.2013.427","article-title":"The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential","volume":"85","author":"Fujita","year":"2014","journal-title":"Kidney Int."},{"issue":"October (10)","key":"10.1016\/j.phrs.2018.01.013_bib1400","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrneph.2017.123","article-title":"GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes","volume":"13","author":"Muskiet","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"issue":"November (1)","key":"10.1016\/j.phrs.2018.01.013_bib1405","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1080\/0886022X.2017.1279553","article-title":"Renoprotective effects of a dipeptidyl peptidase 4 inhibitor in a mouse model of progressive renal fibrosis","volume":"39","author":"Uchida","year":"2017","journal-title":"Ren. Fail."},{"issue":"March (13)","key":"10.1016\/j.phrs.2018.01.013_bib1410","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1074\/jbc.M117.779520","article-title":"SGLT2 protein expression is increased in human diabetic nephropathy: SGLT2 protein inhibition decreases renal lipid accumulation, inflammation, and the development of nephropathy in diabetic mice","volume":"292","author":"Wang","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"November (22)","key":"10.1016\/j.phrs.2018.01.013_bib1415","article-title":"Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model","author":"Mishima","year":"2017","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.phrs.2018.01.013_bib1420","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/ndt\/6.2.105","article-title":"Oral sorbent suppresses accumulation of albumin-bound indoxyl sulphate in serum of haemodialysis patients","volume":"6","author":"Niwa","year":"1991","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.phrs.2018.01.013_bib1425","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1744-9987.2007.00430.x","article-title":"AST- 120, an oral adsorbent, delays the initiation of dialysis in patients with chronic kidney diseases","volume":"11","author":"Ueda","year":"2007","journal-title":"Ther. Apher. Dial."},{"key":"10.1016\/j.phrs.2018.01.013_bib1430","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1053\/j.ajkd.2009.05.011","article-title":"Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial","volume":"54","author":"Akizawa","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.phrs.2018.01.013_bib1435","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1681\/ASN.2014010042","article-title":"Randomized placebo-controlled EPPIC trials of AST-120 in CKD","volume":"26","author":"Schulman","year":"2015","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817312082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817312082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:03:08Z","timestamp":1760911388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661817312082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":287,"alternative-id":["S1043661817312082"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2018.01.013","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiota, hypertension and chronic kidney disease: Recent advances","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2018.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}